323 related articles for article (PubMed ID: 17563718)
1. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
Chandler HL; Barden CA; Lu P; Kusewitt DF; Colitz CM
Mol Vis; 2007 Apr; 13():677-91. PubMed ID: 17563718
[TBL] [Abstract][Full Text] [Related]
2. Activation of SRC kinases signals induction of posterior capsule opacification.
Walker JL; Wolff IM; Zhang L; Menko AS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2214-23. PubMed ID: 17460282
[TBL] [Abstract][Full Text] [Related]
3. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
4. Effects of nuclear factor-kappaB small interfering RNA on posterior capsule opacification.
Park HY; Kim IT; Lee KM; Choi JS; Park MO; Joo CK
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4707-15. PubMed ID: 20375325
[TBL] [Abstract][Full Text] [Related]
5. Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.
Pot SA; Chandler HL; Colitz CM; Bentley E; Dubielzig RR; Mosley TS; Reid TW; Murphy CJ
Exp Eye Res; 2009 Nov; 89(5):728-34. PubMed ID: 19583956
[TBL] [Abstract][Full Text] [Related]
6. miRNA-181a inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells.
Dong N; Tang X; Xu B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):993-1001. PubMed ID: 25626972
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
9. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
10. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040
[TBL] [Abstract][Full Text] [Related]
11. Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.
Malecaze F; Decha A; Serre B; Penary M; Duboue M; Berg D; Levade T; Lubsen NH; Kremer EJ; Couderc B
Gene Ther; 2006 Mar; 13(5):440-8. PubMed ID: 16251995
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines.
Buecher B; Bouancheau D; Broquet A; Bezieau S; Denis MG; Bonnet C; Heymann MF; Jarry A; Galmiche JP; Blottière HM
Anticancer Res; 2005; 25(1A):225-33. PubMed ID: 15816542
[TBL] [Abstract][Full Text] [Related]
14. Induction of posterior capsule opacification by hyaluronic acid in an ex vivo model.
Chandler HL; Haeussler DJ; Gemensky-Metzler AJ; Wilkie DA; Lutz EA
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1835-45. PubMed ID: 22408013
[TBL] [Abstract][Full Text] [Related]
15. Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior capsule opacification.
Eibl KH; Liegl R; Kernt M; Priglinger S; Kampik A
J Cataract Refract Surg; 2009 May; 35(5):900-5. PubMed ID: 19393891
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A prevents ex vivo PCO formation through induction of autophagy-mediated cell death.
Chandler HL; Gervais KJ; Lutz EA; Curto EM; Matusow RB; Wilkie DA; Gemensky-Metzler AJ
Exp Eye Res; 2015 May; 134():63-72. PubMed ID: 25839646
[TBL] [Abstract][Full Text] [Related]
18. Effects of pulsed fluid lens capsule washing following phacoemulsification on lens epithelial cells and posterior capsule opacification formation ex vivo.
Lutz EA; Gemensky-Metzler AJ; Wilkie DA; Chandler HL
Vet Ophthalmol; 2015 May; 18(3):221-8. PubMed ID: 24447772
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas.
Wu R; Abramson AL; Shikowitz MJ; Dannenberg AJ; Steinberg BM
Clin Cancer Res; 2005 Sep; 11(17):6155-61. PubMed ID: 16144915
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M
Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
